Utah Medical Products, Inc.
UTMD
$52.30
-$0.10-0.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -18.56% | -14.35% | -10.28% | -6.54% | -3.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.56% | -14.35% | -10.28% | -6.54% | -3.93% |
| Cost of Revenue | -16.97% | -10.09% | -3.62% | 0.56% | 0.51% |
| Gross Profit | -19.62% | -17.11% | -14.39% | -10.91% | -6.70% |
| SG&A Expenses | -31.17% | -28.19% | -18.55% | -8.92% | 0.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.81% | -15.31% | -7.92% | -2.23% | 0.61% |
| Operating Income | -14.68% | -12.80% | -13.92% | -13.03% | -10.88% |
| Income Before Tax | -16.36% | -11.90% | -11.38% | -6.97% | -2.76% |
| Income Tax Expenses | -15.23% | -21.60% | -20.02% | -17.21% | -17.51% |
| Earnings from Continuing Operations | -16.60% | -9.74% | -9.39% | -4.52% | 0.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.60% | -9.74% | -9.39% | -4.52% | 0.99% |
| EBIT | -14.68% | -12.80% | -13.92% | -13.03% | -10.88% |
| EBITDA | -25.15% | -24.17% | -20.72% | -16.04% | -10.69% |
| EPS Basic | -13.77% | -8.18% | -8.79% | -4.37% | 1.25% |
| Normalized Basic EPS | -10.01% | -5.89% | -5.62% | -3.05% | 1.15% |
| EPS Diluted | -13.71% | -8.08% | -8.72% | -4.56% | 1.21% |
| Normalized Diluted EPS | -9.84% | -5.72% | -5.51% | -3.03% | 1.13% |
| Average Basic Shares Outstanding | -3.46% | -1.79% | -0.72% | -0.16% | -0.28% |
| Average Diluted Shares Outstanding | -3.64% | -1.98% | -0.85% | -0.19% | -0.26% |
| Dividend Per Share | 1.69% | 1.69% | 1.70% | 1.71% | 1.72% |
| Payout Ratio | 0.19% | 0.12% | 0.12% | 0.06% | 0.34% |